SCHEMBL6971260

SCHEMBL6971260

CN(C)Cc1cccc(N/C(=C2\C(=O)Nc3ccc(C(=O)N(C)C)cc32)c2ccccc2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK3 P52333 1/20 0.41
ALDH1A1 P00352 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KIT P10721 1/20 0.39
PDGFRA P16234 1/20 0.39
KDR P35968 1/20 0.39
PTGES O14684 1/20 0.37
TP53 P04637 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
SIRT2 Q8IXJ6 1/20 0.36
SIRT1 Q96EB6 1/20 0.36
SIRT3 Q9NTG7 1/20 0.36
ROCK2 O75116 3/20 0.36
BRD4 O60885 1/20 0.36
KDM1A O60341 1/20 0.36
RCOR1 Q9UKL0 1/20 0.36
NPSR1 Q6W5P4 1/20 0.35
IGF1R P08069 1/20 0.35
PDPK1 O15530 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6971265 1.00 JAK3 (0.41) JAK3ALDH1A1SMN1; SMN2KITPDGFRA
SCHEMBL8189893 0.93 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2TP53MEN1KMT2A
SCHEMBL8189897 0.93 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2TP53MEN1KMT2A
SCHEMBL16684971 0.93 PTGES (0.39) JAK3ALDH1A1SMN1; SMN2KITPDGFRA
SCHEMBL29351460 0.93 PTGES (0.39) JAK3ALDH1A1SMN1; SMN2KITPDGFRA
SCHEMBL12700719 0.93 PTGES (0.39) JAK3ALDH1A1SMN1; SMN2KITPDGFRA
SCHEMBL16684970 0.93 PTGES (0.39) JAK3ALDH1A1SMN1; SMN2KITPDGFRA
SCHEMBL8191861 0.92 KIT (0.39) ALDH1A1SMN1; SMN2KITPDGFRAKDR
SCHEMBL6982734 0.92 PPARG (0.39) ALDH1A1SMN1; SMN2KITPDGFRAKDR
SCHEMBL8191858 0.92 KIT (0.39) ALDH1A1SMN1; SMN2KITPDGFRAKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1071665-B1 SUBSTITUTED INDOLINONES HAVING AN INHIBITING EFFECT ON KINASES AND CYCLINE/CDK COMPLEXES BOEHRINGER INGELHEIM PHARMA (DE) 2003-10-01 EP disclosed
US-6169106-B1 ANTITUMOUR AGENTS BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-01-02 US disclosed